-
Intec Pharma (NTEC) Prices 6.75M Offering at $5.25/Share
-
Intec Pharma Announces Pricing of $35.4 Million Public Offering of Ordinary Shares
-
Intec Pharma Announces Closing of $57.5 Million Public Offering of Ordinary Shares
-
Intec Pharma (NTEC) Prices 10.6M Share Offering at $4.70/Sh
-
Intec Pharma Announces Pricing of $50.0 Million Public Offering of Ordinary Shares
-
Intec Pharma Reports 2015 Fourth Quarter and Full-Year Financial Results
-
Intec Pharma Reports Results for the Third Quarter of 2015
-
Intec Pharma Ltd. Announces Partial Exercise of Underwriters Option to Purchase Additional Ordinary Shares
-
Roth Capital Starts Intec Pharma Ltd. (NTEC) at Buy
-
Intec Pharma Ltd. Announces Closing of U.S. Initial Public Offering
-
Intec Pharma (NTEC) IPO Opens Flat
-
Intec Pharma (NTEC) Prices 5.03M Ordinary Share IPO at $6/Share
-
Intec Pharma Ltd. Announces Pricing of U.S. Initial Public Offering